Featured Firms
Presented by BigVoodoo
The Hatch-Waxman Act became law more than 20 years ago, but still dominates pharmaceutical patent litigation. Evolving far beyond initial expectations, the act is responsible for creating the modern generic drug industry. Michael A. O'Shea and Christopher M. Mikson examine the effects of the Hatch-Waxman Act on competition in the pharmaceutical industry, the latest judicial developments in this area and recent efforts concerning biopharmaceuticals.
February 22, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS